INVO Fertility, Inc. (IVF)

INVO Fertility Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	6.62	6.53	3.02
Revenue Growth (YoY)	119.16%	116.25%	-
Cost of Revenue	4.08	3.66	1.93
Gross Profit	2.54	2.87	1.09
Selling, General & Admin	8.74	9.08	7.49
Research & Development	0.48	0.49	0.17
Operating Expenses	10.09	10.49	7.85
Operating Income	-7.56	-7.61	-6.77
Interest Expense	-1.03	-1.06	-0.93
Currency Exchange Gain (Loss)	-	-	-0
EBT Excluding Unusual Items	-8.61	-8.67	-7.69
Gain (Loss) on Sale of Investments	0.01	0.01	-0.15
Gain (Loss) on Sale of Assets	-	-0.51	-
Other Unusual Items	0.02	0.05	-0.16
Pretax Income	-9.98	-9.12	-8.01
Income Tax Expense	-0.02	-0.02	0.03
Net Income	-27.94	-9.1	-8.03
Preferred Dividends & Other Adjustments	0.25	0.25	-
Net Income to Common	-28.19	-9.35	-8.03
Shares Outstanding (Basic)	0	0	0
Shares Outstanding (Diluted)	0	0	0
Shares Change (YoY)	428.38%	159.54%	-
EPS (Basic)	-134.22	-90.58	-202.10
EPS (Diluted)	-134.22	-90.58	-202.11
Free Cash Flow	-6.62	-3.16	-5.2
Free Cash Flow Per Share	-31.53	-30.61	-130.80
Gross Margin	38.30%	44.00%	35.96%
Operating Margin	-114.15%	-116.56%	-224.03%
Profit Margin	-425.88%	-143.09%	-266.00%
Free Cash Flow Margin	-100.06%	-48.35%	-172.14%
EBITDA	-6.69	-6.69	-6.57
EBITDA Margin	-101.06%	-102.48%	-217.38%
D&A For EBITDA	0.87	0.92	0.2
EBIT	-7.56	-7.61	-6.77
EBIT Margin	-114.15%	-116.56%	-224.03%
Revenue as Reported	6.62	6.53	3.02

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q